文献速递介入腹部US

经皮肝穿刺核心针活检疼痛:肋间与肋下入路随机对照试验

Pain in percutaneous liver core-needle biopsy: a randomized trial comparing the intercostal and subcostal approaches.
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

该随机双盲研究纳入2017年7月至2018年1月转诊至介入放射科行超声引导下肝核心针活检的患者,比较肋间与肋下入路术后疼痛。两组术后即刻疼痛无显著差异(p=0.055),术后2小时(7.5 mm,p=0.001)和4小时(2 mm,p=0.001)差异有统计学意义,但均低于临床重要阈值13 mm,作者建议尽可能采用肋下入路,但不支持肋间入路术后常规使用镇痛药。

要点

  • 术后2小时和4小时肋间与肋下入路疼痛差异有统计学意义,但均未达临床重要阈值13 mm。
  • 术后即刻两组疼痛差异无统计学意义(p=0.055)。
  • 作者建议超声引导下肝活检尽可能采用肋下入路。

核心结论

  • 肋间与肋下入路肝活检术后2小时和4小时疼痛差异有统计学意义但无临床意义,作者建议尽可能采用肋下入路,但不支持肋间入路术后常规使用镇痛药。

研究设计与样本

  • 随机双盲研究,纳入2017年7月至2018年1月转诊至介入放射科行超声引导下肝核心针活检的患者,随机分为肋间入路组和肋下入路组,所有活检未使用程序性静脉镇静。

诊断标准与关键数值

  • 采用100 mm视觉模拟量表评估术后0、2、4小时疼痛强度。
  • 临床重要VAS评分最小变化值为100 mm量表中的13 mm。
  • 术后2小时疼痛差异为7.5 mm(p=0.001),术后4小时为2 mm(p=0.001)。

临床应用与阅片要点

  • 作者建议超声引导下肝活检尽可能采用肋下入路。
  • 作者认为结果不支持肋间入路肝活检术后常规使用镇痛药。

局限性

  • 术中或术后因不适需静脉镇痛药的患者被排除在研究之外。
  • 作者指出结果不支持常规使用术后镇痛药,但未进一步说明其他局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Effective pain control during and after percutaneous core needle liver biopsy is important with regard to ethical considerations and patient comfort. In this randomized double-blind study, we compared post-biopsy pain in the patients undergoing liver core-needle biopsy using either subcostal or intercostal approaches.

METHODS: All patients referred for ultrasound-guided CNLB between July 2017 and January 2018 to our interventional radiology department were randomized into two groups. Biopsy was performed through intercostal approach in the first group and through subcostal approach in the second group. The intensity of pain 0, 2, and 4 h after the procedure was compared in two groups using a 100-mm visual analogue scale. All biopsies were performed without procedural IV sedation. If patients' discomfort demanded administration of IV analgesics during or after the procedure, then the patients were excluded from the study.

RESULTS: In patients without routine procedural IV sedation, there was no significant difference in the pain level between the intercostal and subcostal groups immediately after the procedure (p = 0.055), but we found a significant difference in the pain level between the two groups 2 (7.5 mm, p = 0.001) and 4 (2 mm, p = 0.001) h after the procedure.

CONCLUSION: The minimum amount of change in the VAS score that is considered clinically important is 13 mm on a 100-mm scale. Pain differences at 2 and 4 h in the two groups in this study were statistically but not clinically significant. Therefore, the authors suggest the use of subcostal route for ultrasound-guided liver biopsy whenever possible, but the results do not warrant the routine use of post-procedure analgesics in whom biopsy is performed via intercostal route.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Pezeshki Rad M, Abbasi B, Morovatdar N, et al. Pain in percutaneous liver core-needle biopsy: a randomized trial comparing the intercostal and subcostal approaches. Abdom Radiol (NY). 2019. PMID: 30066171. doi:10.1007/s00261-018-1704-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。